Literature DB >> 1915504

Can high-dose immunoglobulin therapy be indicated in neonatal rhesus haemolysis? A successful case of haemolytic disease due to rhesus (c + E) incompatibility.

S Kubo1, T Ariga, H Tsuneta, T Ishii.   

Abstract

A male neonate with hyperbilirubinaemia and progressing anaemia due to rhesus (c + E) incompatibility received high dose intravenous gammaglobulin (ivIgG) therapy at 13 days of age. Clinical response to therapy was confirmed by a rapid decrease in serum bilirubin level, and with the prevention of a further decline of the haemoglobin level. No side-effects were noted. High dose ivIgG therapy could be an alternative to (exchange) blood transfusion in case of some haemolytic diseases of newborn.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1915504     DOI： 10.1007/bf01958434

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


  6 in total

1.  Treatment of immune hemolytic anemia with gammaglobulin.

Authors: 
Journal:  J Pediatr       Date:  1987-05       Impact factor: 4.406

2.  Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin.

Authors:  G Berlin; A Selbing; G Ryden
Journal:  Lancet       Date:  1985-05-18       Impact factor: 79.321

Review 3.  Clinical uses of intravenous immunoglobulins.

Authors:  S A Berkman; M L Lee; R P Gale
Journal:  Ann Intern Med       Date:  1990-02-15       Impact factor: 25.391

4.  High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization.

Authors:  C de la Cámara; R Arrieta; A González; E Iglesias; F Omeñaca
Journal:  N Engl J Med       Date:  1988-02-25       Impact factor: 91.245

5.  High-dose intravenous intact IgG infusion in refractory autoimmune hemolytic anemia (Evans syndrome).

Authors:  H Oda; A Honda; K Sugita; A Nakamura; H Nakajima
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

6.  Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia.

Authors:  M Derycke; M Dreyfus; J C Ropert; G Tchernia
Journal:  Arch Dis Child       Date:  1985-07       Impact factor: 3.791
  6 in total
  2 in total

1.  International guidelines regarding the role of IVIG in the management of Rh- and ABO-mediated haemolytic disease of the newborn.

Authors:  Lani Lieberman; Enrico Lopriore; Jillian M Baker; Rachel S Bercovitz; Robert D Christensen; Gemma Crighton; Meghan Delaney; Ruchika Goel; Jeanne E Hendrickson; Amy Keir; Denise Landry; Ursula La Rocca; Brigitte Lemyre; Rolf F Maier; Eduardo Muniz-Diaz; Susan Nahirniak; Helen V New; Katerina Pavenski; Maria Cristina Pessoa Dos Santos; Glenn Ramsey; Nadine Shehata
Journal:  Br J Haematol       Date:  2022-04-12       Impact factor: 8.615

Review 2.  Immunoglobulin for alloimmune hemolytic disease in neonates.

Authors:  Carolien Zwiers; Mirjam Ea Scheffer-Rath; Enrico Lopriore; Masja de Haas; Helen G Liley
Journal:  Cochrane Database Syst Rev       Date:  2018-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.